Fenwick & West and Willkie Farr & Gallagher advised Wealthfront on the deal. Wealthfront, an automated wealth management provider serving the next generation of investors, announced...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Sema4 on the deal. Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an...
You must be a Standard 1 Year member to access this content.
Fenwick represented Bolt on the deal. Bolt, an online checkout experience platform, announced its Series E financing. The round was led by BlackRock with participation from new...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised 6Sense on the deal. 6Sense, a leading platform for B2B organizations generating predictable revenue, announced its $200 million Series E financing. The round...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Lyra Health on the deal. Lyra Health, a leading provider of innovative Workforce Mental Health solutions for employers, announced its $235 million financing....
You must be a Standard 1 Year member to access this content.
Fenwick & West and Wilson Sonsini Goodrich & Rosati advised Metagenomi on the deal while Gunderson Dettmer represented PFM Health Sciences. Metagenomi, a genetic medicines company...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Royalty Pharma on the deal. Royalty Pharma (Nasdaq: RPRX), a buyer of biopharmaceutical royalties and funder of innovation across the biopharmaceutical industry,...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised TigerConnect on the deal. TigerConnect, maker of a powerful healthcare software collaboration suite, announced its strategic growth investment from Vista Equity Partners, a...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Merit on the deal. Merit, a verified identity platform, announced its $50 million Series B financing. Rose Park Advisors led the financing round...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised DexCare on the deal. DexCare, a data-driven intelligence company focused on healthcare access, announced its $50 million Series B financing. The round was...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Swell on the deal. Swell, a headless ecommerce platform, announced its $20 million Series A financing. The round was led by VMG Catalyst...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Ironclad on the deal. Ironclad, a digital contracting platform that provides software for businesses to manage contract lifecycles, announced its $150 million Series...
You must be a Standard 1 Year member to access this content.
